Catalent

Catalent is a global contract development and manufacturing organization (CDMO) headquartered in the US. It supports pharmaceutical and biotech customers across the product lifecycle, including oral solid dose, softgel, clinical supply, consumer health and gene therapy manufacturing.

Investment rationale 

Catalent provides exposure to pharmaceutical development and manufacturing outsourcing. Its scale, specialised capabilities and presence in complex, high-barrier production position the company to benefit as drug developers seek partners with flexible capacity and technical expertise across the product lifecycle.

Headquarters: Florida, USA

Website: https://www.catalent.com/ 

Responsible partner: Jannick Mortensen

Fund: MIM II